Organisation › Details

Celonic (Group)

Celonic AG is a privately owned CDMO based in Basel, Switzerland, providing comprehensive GMP development and manufacturing services for New Biological Entities (NBEs) and Biosimilars worldwide. Applying empathy, efficiency and excellence, Celonic goes one step beyond expectations in all business aspects in order to help its clients attain their goals more efficiently and reliably. Celonic’s services include the development of cell lines, production processes, as well as the GMP and non-GMP manufacturing of biopharmaceutical drug substances. In addition, Celonic licenses its proprietary CHOvolution™ cell line technology to clients, drug developer and service provider. *


Period Start 1998-05-01 established
Products Industry cell line development (recombinant protein production)
  Industry 2 contract manufacturing (biologicals)
Person Person Matentzoglu, Konstantin (Celonic 201711 CEO before Trenzyme GmbH 201202 Managing Director)
Region Region Basel BS
  Country Switzerland
  Street 55 Eulerstr.
  City 4051 Basel
  Tel +41-61-654915-0
    Address record changed: 2018-11-07
Basic data Employees C: 51 to 100 (2017-10-26)
    * Document for �About Section�: Celonic AG. (9/5/16). "Press Release: Celonic and IBI-Lorenzini Announce a Strategic Collaboration on CHOvolution, an Innovative Integrated Cell Line Development Platform". Basel & Aprilia.
Record changed: 2018-11-07


Picture [LSUK] – The Business Web Portal 650x99px

More documents for Celonic (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


[iito] Business Intelligence – The Elephants Are Coming 560x113px

» top